Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

Por Gal Cohen, Maya Shavit, Netanella Miller, Rimon Moran, Yael Yagur, Omer Weitzner, Michal Ovadia, Hanoch Schreiber, Gil Shechter-Maor, Tal Biron-Shental
Publicado em 2022-01-01